Skip to main content

Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.

Chung KY, Quek JM, Neo SH, Too HP

Publication: J Mol Diagn (2020) • Vol 22 • Page 610-618PMID: 32151712View on PubMed

Purpose

The purpose of this paper was to compare extracellular vesicle (EV) recovery from serum using ultracentrifugation, column affinity, peptide affinity, immune affinity, and four polymer-based methods by comparing levels of microRNAs (miRNAs, miR) by real-time RT-PCR and levels of EV markers by Western Blot. The four polymer-based methods were also used to identify potential EV miRNA biomarkers for gastric cancer.

Conclusion

The EV markers were detected by Western blot in all EV isolates but the relative expression differed among methods, indicating different efficiency of isolation of the EV subtypes. Albumin contamination was lowest when EV isolation was with ultracentrifugation followed by the Total Exosome Isolation from Serum Kit and the ExoQuick Exosome Precipitation Solution Kit. The recovery percentage relative to serum of the 11 miRNAs assayed was highest when exosomes were isolated using polymer-based precipitation methods (20-30%) followed by ultracentrifugation, the column affinity-based exoRNeasy Kit, and the peptide affinity-based ME Kit; each of which recovered 4-15% of the miRNA. Among the polymer-based methods, the highest miRNA recovery was found when isolation was with the miRCURY Exosome Isolation Kit for Serum and Plasma. Of the 133 serum miRNAs assayed, 104 were detected in all EV isolates. More significant differences in expression between healthy pools and gastric cancer pools was found in EVs than serum for 11 miRNAs when EVs were isolated with the Total Exosome Isolation from Serum Kit, seven miRNAs when EVs were isolated with the EXO-prep Kit, and five miRNAs when EVs were isolated with the ExoQuick Exosome Precipitation Solution kit or miRCURY Exosome Isolation Kit. Further investigation using EVs isolated with the Total Exosome Isolation from Serum Kit found that expression of 8 of the 11 miRNAs had enhanced differential expression in gastric cancer when EVs were assayed rather than serum; all of which had higher GC detection accuracy when measured in EVs than in serum.

Studies (1)

Purpose

The purpose of this study was to compare EV recovery from serum using ultracentrifugation, column affinity, peptide affinity, immune affinity, and four polymer-based methods by comparing levels of miRNA by real-time PCR and levels of EV markers by Western Blot. The four polymer-based methods were also used to identify potential EV miRNA biomarkers for gastric cancer. Commercial serum pools from healthy patients (35 pools) and those with gastric cancer (35 pools) were purchased from BioIVT and centrifuged at 2000 x g for 20 minutes followed by 10,000 x g for 30 min. EVs were isolated from one serum pool (diagnosis not specified) by ultracentrifugation (100,000 x g for 70 minutes at 4°C twice), column affinity-based exoRNeasy Serum/Plasma Midi Kit, peptide affinity-based ME Kit, and the immunity-affinity based ExoCap Composite Kit for Serum and Plasma; from 30 serum pools using polymer-based precipitation kits (Total Exosome Isolation from Serum Kit, ExoQuick Exosome Precipitation Solution Kit, miRCURY Exosome Isolation Kit for Serum and Plasma, and EXO-prep Kit); and from the remaining 40 pools only with the Total Exosome Isolation from Serum Kit. RNA was isolated from serum and EV preparations using the miRNeasy serum/plasma miRNA Isolation Kit using a QIAcube. RNA from EV and serum isolates from a healthy pool was reverse transcribed and real-time PCR amplified using ID3EAL cDNA synthesis and qPCR reagents with specific stem-loop primers for let-7a-5p, miR-103a-3p, miR-146a-5p, miR-16-5p, miR-191-5p, miR-20a-5p, miR-21-5p, miR-23a-3p, miR-30c-5p, miR-451a, and miR-93-5p. Levels of 133 miRNAs were assayed in RNA extracted from all EVs that were isolated using the polymer-based methods using a multiplex reverse transcription primer pools ID3EAL and the ID3EAL cDNA synthesis reagent. miRNA recovery was as a percentage of total miRNA in serum. Protein levels in exosomes were quantified by Western Blot using antibodies against flotillin, TSG101, CD63, CD81, CD9, and albumin.

Summary of Findings

The EV markers flotillin, TSG101, CD9, CD63, and CD81 were detected by Western blot in all EV isolates but the relative expression differed among methods, indicating different efficiency of isolation of the EV subtypes. Importantly, albumin contamination was lowest when isolation was with ultracentrifugation followed by the Total Exosome Isolation from Serum Kit and the ExoQuick Exosome Precipitation Solution Kit. The recovery percentage relative to serum of the 11 miRNAs assayed was highest when exosomes were isolated using polymer-based precipitation methods (20-30%) followed by ultracentrifugation, the column affinity-based exoRNeasy Kit, and the peptide affinity-based ME Kit; each of which recovered 4-15% of the miRNAs. The miRNA in exosomes isolated with the immunity affinity-based ExoCap Composite Kit was <5% of that isolated from serum. Among the polymer-based methods, the highest miRNA recovery was found when isolation was with the miRCURY Exosome Isolation Kit for Serum and Plasma and lowest when isolation was with the EXO-prep Kit. All 133 miRNAs were detected in all 30 total serum pools (15 gastric cancer and 15 healthy) and 104 miRNAs were detected in all EV isolates. More significant differential expression between healthy pools and gastric cancer pools were found for EVs than serum for 11 miRNAs when EV were isolated with the Total Exosome Isolation from Serum Kit, seven miRNAs when EVs were isolated with the EXO-prep Kit, and five miRNAs when EVs were isolated with the ExoQuick Exosome Precipitation Solution Kit or miRCURY Exosome Isolation Kit. Further investigation using EVs isolated with the Total Exosome Isolation from Serum Kit from another 40 pools (20 healthy and 20 gastric cancer) found that expression of 8 of the 11 miRNAs had enhanced differential expression in gastric cancer when EVs were assayed rather than serum; all of which had higher GC detection accuracy when measured in EVs than in serum.

  • Biospecimens

    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
    Normal
  • Platforms

    RNAReal-time qRT-PCR
    ProteinWestern blot
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Gastric cancer
    Healthy
    Biospecimen Aliquots and ComponentsBlood and blood products
    Serum
    Serum vesicles
    Analyte Extraction and PurificationAnalyte isolation method
    Column affinity-based exoRNeasy Serum/Plasma Midi Kit
    EXO-prep Kit
    ExoQuick Exosome Precipitation Solution Kit
    Immunity-affinity based ExoCap Composite Kit for Serum
    Peptide affinity based ME Kit
    Serum
    Total Exosome Isolation from Serum Kit
    Ultracentrifugation (100,000 x g for 70 minutes at 4°C twice)
    miRCURY Exosome Isolation Kit for Serum and Plasma
    Real-time qRT-PCR SpecificTargeted nucleic acid
    133 miRNA
    let-7a-5p
    miR-103a-3p
    miR-146a-5p
    miR-16-5p
    miR-191-5p
    miR-20a-5p
    miR-21-5p
    miR-23a-3p
    miR-30c-5p
    miR-451a
    miR-93-5p
    Western blot SpecificTargeted peptide/protein
    Albumin
    CD63
    CD81
    CD9
    Flotillin
    TSG101